In de novo AML patients excluding those with APL, the CR rate was not significantly different between patients with FLT3/ITD mutation and those without FLT3/ITD mutation. The FLT3/ITDs turned negative in patients with FLT3/ITD mutation in CR.

• 在非M3患者中；FLT3/ITD阳性者的完全缓解率与阴性者比较；差异无统计学意义(P>0.；05)；FLT3/ITD阳性患者完全缓解后检测FLT3/ITD转阴性。